Barr, Ian G.
Donis, Ruben O.
Katz, Jacqueline M.
McCauley, John W.
Odagiri, Takato
Trusheim, Heidi
Tsai, Theodore F.
Wentworth, David E.
Funding for this research was provided by:
US Department of Health and Human Services
Australian Government Department of Health
Crick Institute, an independent non-profit organization in the UK
National Institute of Infectious Diseases in Japan
Article History
Received: 7 May 2018
Revised: 3 August 2018
Accepted: 7 August 2018
First Online: 9 October 2018
Competing interests
: WHO Collaborating Centers based in Melbourne (VIDRL) and Atlanta (Influenza Division, CDC) received funds under a Cooperative Research and Development Agreement with Seqirus to produce and characterize cell culture-based candidate vaccine viruses. I.G.B. owns shares in a company that produces influenza vaccine. T.F.T. is a full time employee of Takeda Vaccines, a manufacturer of cell culture-based pandemic influenza vaccines.